文献速递主动脉外科

B型主动脉夹层二十年经验:芬兰全国人群登记研究

Twenty years' experience of type B aortic dissections: a population-based national registry study from Finland.
PubMed 文献 · Interdiscip Cardiovasc Thorac Surg · 2023-01-01

该研究基于芬兰全国健康照护登记数据,纳入2000至2019年15岁以上B型主动脉夹层患者1742例,分析发生率、治疗与生存。B型夹层占所有主动脉夹层住院的45.6%,年发生率1.62/10万。胸主动脉腔内修复(TEVAR)、手术和药物治疗中位生存分别为12.7年、12.4年和8.6年;TEVAR和手术后生存显著优于单纯药物治疗(P<0.001)。

要点

  • B型主动脉夹层占所有主动脉夹层住院的45.6%,年发生率1.62/10万。
  • TEVAR、手术和药物治疗中位生存分别为12.7年、12.4年和8.6年。
  • TEVAR和手术后生存显著优于单纯药物治疗(P<0.001)。

核心结论

  • 芬兰人群B型主动脉夹层发生率似乎与其他人群研究相似。
  • 接受TEVAR治疗的患者生存显著优于其他患者。
  • 应认识到B型主动脉夹层患者晚期主动脉相关死亡的高风险。

研究设计与样本

  • 研究为基于芬兰全国健康照护登记(Nationwide Care Register for Health Care,芬兰国家健康与福利研究所)的人群登记研究。
  • 纳入2000至2019年所有15岁以上B型主动脉夹层患者。
  • 通过死亡原因登记(芬兰统计)检索死亡日期和死因。

主要发现

  • 研究期间共有1742例B型主动脉夹层。
  • B型主动脉夹层占所有导致住院的主动脉夹层的45.6%。
  • B型主动脉夹层年发生率为1.62/10万居民。
  • TEVAR、手术和药物治疗的中位生存分别为12.7年(95%CI 9.63-14.7)、12.4年(95%CI 10.5-14.4)和8.6年(95%CI 7.5-9.7)。
  • TEVAR和手术后生存显著优于单纯药物治疗(P<0.001)。

关键数值与推荐

  • 年龄校正后,TEVAR后生存显著优于药物或手术治疗(HR 0.578,95%CI 0.420-0.794,P<0.001)。
  • 主动脉相关死亡是所有组中最常见死因(41%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The objective of this study was to investigate the incidence, treatment and survival of Stanford type B aortic dissection (BTAD) during 20 years in the Finnish population. METHODS: Data collection was made from the Nationwide Care Register for Health Care, Finnish National Institute for Health and Welfare. All patients over 15 years of age with BTAD from 2000 to 2019 were included in the study. A data search of the Registry of Death Cause (Statistic Finland) was carried out to identify the date and cause of death. RESULTS: There were 1742 cases of BTAD during the study period. BTAD represented 45.6% of all aortic dissections leading to hospital admission. Incidence for BTAD was 1.62 per 100 000 inhabitants per year. The median survival was 12.7 years [95% confidence interval (CI) 9.63-14.7], 12.4 years (95% CI 10.5-14.4) and 8.6 years (95% CI 7.5-9.7) for patients treated with thoracic endovascular aortic repair (TEVAR), surgery and medical treatment (MT), respectively. Survival was significantly better after TEVAR and surgery, compared to MT only (P < 0.001). Age-adjusted survival was significantly better after TEVAR compared to patients treated with MT or surgery (hazard ratio 0.578, 95% CI 0.420-0.794, P < 0.001). Aortic-related death was the most common cause of death in all groups (41%). CONCLUSIONS: The incidence of BTAD seems to be similar in the Finnish population compared to other populational studies. Patients treated with TEVAR had significantly better survival compared to other patients. A high risk for late aortic-related death should be recognized in patients with BTAD.

来源:Interdiscip Cardiovasc Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Toimela JM, Sedha J, Hedman M, et al. Twenty years' experience of type B aortic dissections: a population-based national registry study from Finland. Interdiscip Cardiovasc Thorac Surg. 2023. PMID: 37947327. doi:10.1093/icvts/ivad184

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。